The Correlation Between Biofilm-Forming Ability of Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolated from the Respiratory Tract and Clinical Characteristics in Children
Shumin Huang,Jing He,Yiting Zhang,Lin Su,Lin Tong,Ying Sun,Mingming Zhou,Zhimin Chen
DOI: https://doi.org/10.2147/IDR.S370755
2022-07-12
Infection and Drug Resistance
Abstract:Shumin Huang, 1, 2 Jing He, 1, 2 Yiting Zhang, 1, 2 Lin Su, 1, 2 Lin Tong, 1, 2 Ying Sun, 1, 2 Mingming Zhou, 2, 3 Zhimin Chen 1, 2 1 Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, People's Republic of China; 2 National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, 310052, People's Republic of China; 3 Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, People's Republic of China Correspondence: Zhimin Chen, Email Objective: This study aimed to investigate the biofilm-forming ability, molecular typing, and antimicrobial resistance of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) strains isolated from the respiratory tract of children and their correlation with clinical characteristics. Methods: All CA-MRSA strains were isolated from hospitalized children, and their presentation, molecular typing, antimicrobial susceptibility, and biofilm formation were investigated. The clinical characteristics were compared between the strong and weak biofilm producer groups. Results: Fifty-three CA-MRSA strains were isolated from the respiratory samples of 53 children, with nearly half of them being young infants (0– 12 months). Approximately, 88.7% (47/53) of the isolates were resistant to four or more antibiotics, mainly β-lactam antibiotics, lincosamides, and macrolides. Twelve sequence types (STs) and 20 subtypes of staphylococcal protein A (spa) typing were identified, with ST59-t437 (39.6%, 21/53) as the predominant subtype. All strains showed the ability to form biofilms. When compared to children with weak biofilm-forming CA-MRSA strains, those with strong biofilm-forming strains had higher proportions of lower respiratory tract infections (LRTI) (88.5% vs 59.3%), obvious cough symptoms (84.6% vs 51.9%), and severe chest imaging manifestations (76.9% vs 37.0%). Furthermore, a strong biofilm-forming ability significantly increased the risk of prolonged cough in children with LRTI (44.4% vs 14.3%), and a positive correlation between the duration of cough and the extent of biofilm formation was observed. Medical history investigation revealed that the strong biofilm-forming group had a much higher percentage of macrolides intake than the weak biofilm-forming group in the last month before admission (61.5% vs 14.8%). Conclusion: ST59-t437 was the most prevalent clone in CA-MRSA respiratory isolates among the hospitalized children. All CA-MRSA strains formed biofilms. The stronger the biofilm-forming ability, the more serious and prolonged were the respiratory symptoms. Keywords: CA-MRSA, biofilm, respiratory infection, child, genotype Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen and the most common multidrug-resistant bacterium that causes nosocomial infections, with high morbidity and mortality. MRSA is closely associated with health care settings. 1 However, since the 1990s, MRSA infections have increased among people without hospital-related risk factors worldwide. 2,3 Furthermore, there have been notable epidemics, such as the USA300, which spread internationally and caused many deaths. 4,5 All of these are associated with the emergence of new MRSA clones known as community-acquired MRSA (CA-MRSA). Compared to hospital-acquired MRSA (HA-MRSA), CA-MRSA is more clonally diverse and highly virulent because it produces Panton-Valentine leukocidin (PVL) exotoxin and is more likely to cause severe infections, particularly among young, healthy individuals. 6–9 Additionally, more CA-MRSA strains contain the staphylococcal cassette chromosome mec (SCCmec) element type IV or V, conferring resistance to β-lactam antibiotics. 8,9 It can cause a wide spectrum of clinical diseases, from the skin and soft tissue infections (SSTIs) to severe invasive infections, accounting for a large proportion of the increased disease burden observed in the last decade, particularly among children. 6,7,9–11 Biofilms are bacterial aggregates embedded in a matrix composed of extracellular polysaccharides, fibrin, and other substances produced by bacteria. They are highly resistant to antibiotics and host immunity, making biofilm-associated infections a major concern in clinical practice. A biofilm can be formed not only on the surface of medical implants but also on mucous membranes. The formation of bacterial biofilms on the respiratory tract has been linked to recurrent res -Abstract Truncated-
pharmacology & pharmacy,infectious diseases